LNG IUS

DEVICE2 trials

Sponsors

Bayer, FHI 360

Conditions

AnemiaMenopause

Phase 3

Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).

CompletedNCT00185458

Start: 2000-05-31End: 2008-05-31Updated: 2013-11-27

Unknown Phase

Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya

Active, not recruitingNCT05233956

Start: 2023-10-23End: 2026-12-31Updated: 2026-04-03